Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 15, Issue 6, 2016, Pages 794-801

  Collaco, Joseph M ^a   Raraigh, Karen S ^a   Appel, Lawrence J ^a   Cutting, Garry R ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Climate; Cystic fibrosis; FEV1; Lung function; MRSA; Pseudomonas aeruginosa; Temperature

Indexed keywords

ACHROMOBACTER; ARTICLE; ASPERGILLUS; ATYPICAL MYCOBACTERIUM; BURKHOLDERIA CEPACIA COMPLEX; CHILD; CYSTIC FIBROSIS; ENVIRONMENTAL TEMPERATURE; ESCHERICHIA COLI; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; ADULT; ANALYSIS; ENVIRONMENTAL EXPOSURE; ISOLATION AND PURIFICATION; LUNG; LUNG FUNCTION TEST; MICROBIOLOGY; PATHOPHYSIOLOGY; PREVALENCE; PROCEDURES; PSEUDOMONAS INFECTION; SIBLING; STAPHYLOCOCCUS INFECTION; STATISTICS; TEMPERATURE; TWINS; UNITED STATES;

ADULT; CHILD; CYSTIC FIBROSIS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LUNG; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; SIBLINGS; STAPHYLOCOCCAL INFECTIONS; STATISTICS AS TOPIC; TEMPERATURE; UNITED STATES;

EID: 84998636610     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2016.05.012     Document Type: Article

References (45)

1. [1] Sosnay, P.R., Siklosi, K.R., Van Goor, F., et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet 45 (2013), 1160–1167.
2. [2] Kerem, E., Corey, M., Kerem, B.S., et al. The relation between genotype and phenotype in cystic fibrosis—analysis of the most common mutation (delta F508). N Engl J Med 323 (1990), 1517–1522.
3. [3] Correlation between genotype and phenotype in patients with cystic fibrosis. The Cystic Fibrosis Genotype–Phenotype Consortium. N Engl J Med, 329, 1993, 1308–1313.
4. [4] Koch, C., Cuppens, H., Rainisio, M., et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 31 (2001), 1–12.
5. [5] Collaco, J.M., Blackman, S.M., McGready, J., Naughton, K.M., Cutting, G.R., Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr 157 (2010), 802–807 [e1–3].
6. [6] Stanke, F., Becker, T., Kumar, V., et al. Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. J Med Genet 48 (2010), 24–31.
7. [7] Rowe, S.M., Heltshe, S.L., Gonska, T., et al. Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis. Am J Respir Crit Care Med 190 (2014), 175–184.
8. [8] O'Sullivan, B.P., Orenstein, D.M., Milla, C.E., Pricing for orphan drugs: will the market bear what society cannot?. JAMA 310 (2013), 1343–1344.
9. [9] Collaco, J.M., Vanscoy, L., Bremer, L., et al. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA 299 (2008), 417–424.
10. [10] Campbell, P.W. III, Parker, R.A., Roberts, B.T., Krishnamani, M.R., Phillips, J.A. III, Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion. J Pediatr 120 (1992), 261–264.
11. [11] Rubin, B.K., Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med 323 (1990), 782–788.
12. [12] Smyth, A., O'Hea, U., Williams, G., Smyth, R., Heaf, D., Passive smoking and impaired lung function in cystic fibrosis. Arch Dis Child 71 (1994), 353–354.
13. [13] Beydon, N., Amsallem, F., Bellet, M., et al. Pulmonary function tests in preschool children with cystic fibrosis. Am J Respir Crit Care Med 166 (2002), 1099–1104.
14. [14] O'Connor, G.T., Quinton, H.B., Kneeland, T., et al. Median household income and mortality rate in cystic fibrosis. Pediatrics, 111, 2003 (e333-e9).
15. [15] Schechter, M.S., McColley, S.A., Silva, S., Haselkorn, T., Konstan, M.W., Wagener, J.S., Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr 155 (2009), 634–639.
16. [16] Stephenson, A., Hux, J., Tullis, E., Austin, P.C., Corey, M., Ray, J., Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario, Canada. Pediatr Pulmonol 46 (2011), 376–384.
17. [17] Collaco, J.M., McGready, J., Green, D.M., et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS One, 6, 2011, e27784.
18. [18] Curtis, J.R., Burke, W., Kassner, A.W., Aitken, M.L., Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis. Am J Respir Crit Care Med 155 (1997), 1921–1924.
19. [19] Schechter, M.S., Margolis, P.A., Relationship between socioeconomic status and disease severity in cystic fibrosis. J Pediatr 132 (1998), 260–264.
20. [20] Schechter, M.S., Shelton, B.J., Margolis, P.A., Fitzsimmons, S.C., The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 163 (2001), 1331–1337.
21. [21] Goss, C.H., Newsom, S.A., Schildcrout, J.S., Sheppard, L., Kaufman, J.D., Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med 169 (2004), 816–821.
22. [22] Ranganathan, S.C., Skoric, B., Ramsay, K.A., et al. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Ann Am Thorac Soc 10 (2013), 108–114.
23. [23] Psoter, K.J., Rosenfeld, M., De Roos, A.J., Mayer, J.D., Wakefield, J., Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis. Am J Epidemiol 179 (2014), 1503–1513.
24. [24] Kopp, B.T.N.L., Paul, G., Tobias, J., Ramanathan, C., Hayes, D., Geographic variations in cystic fibrosis in the United States: An analysis of the U.S. Cystic Fibrosis Foundation Patient Registry. Pediatr Pulmonol, 2014, 49.
25. [25] Vanscoy, L.L., Blackman, S.M., Collaco, J.M., et al. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 175 (2007), 1036–1043.
26. [26] Kulich, M., Rosenfeld, M., Campbell, J., et al. Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 172 (2005), 885–891.
27. [27] Baron, R.M., Kenny, D.A., The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 (1986), 1173–1182.
28. [28] Mediation. Accessed 11/29/2014, at http://davidakenny.net/cm/mediate.htm.
29. [29] Hicks, R., Tingley, D., Causal mediation analysis. Stata J 11 (2011), 605–619.
30. [30] Sobel, M.E., Asymptotic intervals for indirect effects in structural equations models. Leinhart, S., (eds.) Sociological Methodology 1982, 1982, Jossey-Bass, San Francisco, CA, 290–312.
31. [31] Calculation for the Sobel Test., 2010–2015 Accessed 12/24/2015, at http://quantpsy.org/sobel/sobel.htm.
32. [32] Lin, M.F., Lucas, H.C., Shmueli, G., Too big to fail: large samples and the p-value problem. Inf Syst Res 24 (2013), 906–917.
33. [33] Patz, J.A., Campbell-Lendrum, D., Holloway, T., Foley, J.A., Impact of regional climate change on human health. Nature 438 (2005), 310–317.
34. [34] Abdallah, M., Benoliel, C., Ferreira-Theret, P., Drider, D., Dhulster, P., Chihib, N.E., Effect of culture conditions on the resistance of Pseudomonas aeruginosa biofilms to disinfecting agents. Biofouling 31 (2015), 49–59.
35. [35] Abdallah, M., Chataigne, G., Ferreira-Theret, P., et al. Effect of growth temperature, surface type and incubation time on the resistance of Staphylococcus aureus biofilms to disinfectants. Appl Microbiol Biotechnol 98 (2014), 2597–2607.
36. [36] Abdallah, M., Benoliel, C., Jama, C., Drider, D., Dhulster, P., Chihib, N.E., Thermodynamic prediction of growth temperature dependence in the adhesion of Pseudomonas aeruginosa and Staphylococcus aureus to stainless steel and polycarbonate. J Food Prot 77 (2014), 1116–1126.
37. [37] Kannan, A., Gautam, P., A quantitative study on the formation of Pseudomonas aeruginosa biofilm. Springer Plus, 4, 2015, 379.
38. [38] Cappello, S., Guglielmino, S.P., Effects of growth temperature on polystyrene adhesion of Pseudomonas aeruginosa ATCC 27853. Braz J Microbiol 37 (2006), 205–207.
39. [39] Roosjen, A., van der Mei, H.C., Busscher, H.J., Norde, W., Microbial adhesion to poly(ethylene oxide) brushes: influence of polymer chain length and temperature. Langmuir 20 (2004), 10949–10955.
40. [40] Chen, L., Hobden, J.A., Masinick, S.A., Hazlett, L.D., Environmental factors influence P aeruginosa binding to the wounded mouse cornea. Curr Eye Res 17 (1998), 231–237.
41. [41] De Soyza, A., Hall, A.J., Mahenthiralingam, E., et al. Developing an international Pseudomonas aeruginosa reference panel. Microbiol Open 2 (2013), 1010–1023.
42. [42] Grundmann, H., Aanensen, D.M., van den Wijngaard, C.C., et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular–epidemiological analysis. PLoS Med, 7, 2010, e1000215.
43. [43] Adjemian, J., Olivier, K.N., Prevots, D.R., Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med 190 (2014), 581–586.
44. [44] Rosenfeld, M., Emerson, J., Accurso, F., et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 28 (1999), 321–328.
45. [45] Bezirtzoglou, C., Dekas, K., Charvalos, E., Climate changes, environment and infection: facts, scenarios and growing awareness from the public health community within Europe. Anaerobe 17 (2011), 337–340.